Holaluz cumple objetivos de EBITDA normalizado y alcanza
Barcelona, 31 de enero de 2024 (GLOBE NEWSWIRE) -- Holaluz-Clidom S.A. (BME:HLZ) cumple objetivos de EBITDA normalizado y alcanza los 3M€ en el ejercicio 2023 ...
Vaxcyte Announces Pricing of $750 Million Public Offering
SAN CARLOS, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to...
Regenx Revises Non-Brokered Financing for Gross Proceeds to
EDMONTON, Alberta, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Regenx Tech Corp. (the "Company" or "Regenx") (CSE: RGX) (OTCQB: RGXTF) (FSE: YRS WKN:A2DSW3)...
Tourmaline Bio Announces Closing of $172.5 Million Public
NEW YORK, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (“Tourmaline”) (Nasdaq: TRML), a late-stage clinical biotechnology company developing transformative medicines...
Ryman Hospitality Properties, Inc. Releases 2024 Guidance
NASHVILLE, Tenn., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Ryman Hospitality Properties, Inc. (NYSE: RHP), a lodging real estate investment trust (“REIT”) specializing...
AURI Token Listing and Partnership With a Top 100
AURI Token Listing on Global Exchange DALLAS, TX, Jan. 30, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Auri Inc....
Zacatecas Silver Arranges $1.8 Million Financing
VANCOUVER, British Columbia, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Zacatecas Silver Corp. (“Zacatecas Silver” or the “Company”, ZAC:TSX Venture; ZCTSF: OTC Markets;...
GRIID to Begin Trading on Nasdaq Global Market Under Ticker
CINCINNATI, Jan. 29, 2024 (GLOBE NEWSWIRE) -- GRIID Infrastructure Inc. (“GRIID” or the “Company”) (NASDAQ: GRDI) (NEO: GRDI), an American infrastructure company...
HEALWELL AI Provides Corporate Update Highlighting its
An important part of HEALWELL’s forward growth and value creation strategy involves acquiring, investing in and/or partnering with data focused companies such as electronic...
AIM ImmunoTech Receives Erasmus Medical Center Ethics Board
OCALA, Fla., Jan. 24, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it has...
Processa Pharmaceuticals Announces Pricing of $7.0 Million
HANOVER, Md., Jan. 26, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused...
BrightSpring Celebrates First Day of Trading on Nasdaq
LOUISVILLE, Ky., Jan. 26, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) today marked its first...
